Education
About Us
Working with TipRanks
Follow Us
Vireo Growth (VREOF)
OTHER OTC:VREOF
VREOF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.23 - $0.80
Previous CloseN/A
Volume345.43K
Average Volume (3M)190.78K
Market Cap
$683.76M
Enterprise Value$404.70M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.09
Next Earnings
Nov 18, 2025EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding923,839,200
10 Day Avg. Volume126,333
30 Day Avg. Volume190,776
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.59
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$0.55Price Target Upside-21.43% Downside
Rating ConsensusHold
Number of Analyst Covering0
Vireo Growth News
VREOF FAQ
What was Vireo Growth’s price range in the past 12 months?
Vireo Growth lowest stock price was $0.23 and its highest was $0.80 in the past 12 months.
What is Vireo Growth’s market cap?
Vireo Growth’s market cap is $683.76M.
When is Vireo Growth’s upcoming earnings report date?
Vireo Growth’s upcoming earnings report date is Nov 18, 2025 which is in 80 days.
How were Vireo Growth’s earnings last quarter?
Vireo Growth released its earnings results on Aug 13, 2025. The company reported -$0.023 earnings per share for the quarter, missing the consensus estimate of $0 by -$0.023.
Is Vireo Growth overvalued?
According to Wall Street analysts Vireo Growth’s price is currently Overvalued.
Does Vireo Growth pay dividends?
Vireo Growth does not currently pay dividends.
What is Vireo Growth’s EPS estimate?
Vireo Growth’s EPS estimate is 0.01.
How many shares outstanding does Vireo Growth have?
Vireo Growth has 923,839,200 shares outstanding.
What happened to Vireo Growth’s price movement after its last earnings report?
Vireo Growth reported an EPS of -$0.023 in its last earnings report, missing expectations of $0. Following the earnings report the stock price went up 10%.
Which hedge fund is a major shareholder of Vireo Growth?
Currently, no hedge funds are holding shares in VREOF
Vireo Growth Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$0.55 (-21.43% Downside)
$0.55 (-21.43% Downside)
Blogger Sentiment
Bullish
VREOF Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $233.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
50.53%
12-Months-Change
Fundamentals
Return on Equity
-34.20%
Trailing 12-Months
Asset Growth
238.68%
Trailing 12-Months
Company Description
Vireo Growth
Vireo Health International, Inc. is a holding company, which engages in the cultivation, production, and sale of medical cannabis. Its products include medical marijuana extracts in the form of oils, vaporizers, and capsules. The company was founded on November 23, 2004 and is headquartered in Minneapolis, MN.
VREOF Company Deck
VREOF Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected strong revenue growth and successful refinancing efforts, improving cash flow and operational efficiency. However, challenges with gross margin, uncertainty in Minnesota's expansion, and regulatory delays in New York asset sales presented notable concerns.View all VREOF earnings summariesTechnical Analysis
ZYUS Life Sciences
―
MTL Cannabis
―
Leef Brands
―
Refined Energy
―
Simply Solventless Concentrates Ltd
―
Ownership Overview
Options Prices
Currently, No data available
---